Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Meijer

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
BMJ Open|July 8, 2022
Opinions on hypertension care and therapy adherence at the healthcare provider and healthcare system level: a qualitative study in the Hague, NetherlandsSaskia E van Grondelle, Sytske van Bruggen, Judith Meijer, et al.
British Journal of Clinical Pharmacology|November 10, 2015
Evaluation of an oral uracil loading test to identify DPD-deficient patients using a limited sampling strategyMaurice C van Staveren, Andre B P van Kuilenburg, Henk-Jan Guchelaar, et al.
Molecular Genetics and Metabolism|October 22, 2017
Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activityYoko Nakajima, Judith Meijer, Doreen Dobritzsch, et al.
Advances in Neurobiology|October 8, 2014
Pregnancy Outcomes After a Maternity Intervention for Stressful Emotions (PROMISES): A Randomised Controlled TrialHuibert Burger, Claudi L H Bockting, Chantal Beijers, et al.
Molecular Genetics and Metabolism|March 27, 2007
Clinical, biochemical and genetic findings in two siblings with a dihydropyrimidinase deficiencyAndré B P van Kuilenburg, Judith Meijer, Doreen Dobritzsch, et al.
International Journal of Cancer|September 21, 2017
Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiencyLinda M Henricks, Ester J M Siemerink, Hilde Rosing, et al.
Human Mutation|April 26, 2018
Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12André B P van Kuilenburg, Maja Tarailo-Graovac, Judith Meijer, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2016
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidinesDidier Meulendijks, Linda M Henricks, André B P van Kuilenburg, et al.
Biochimica Et Biophysica Acta|January 26, 2016
Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase geneAndré B P van Kuilenburg, Judith Meijer, Michael W T Tanck, et al.
The British Journal of Dermatology|January 7, 2022
Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieuSanja Kezic, Maeve A McAleer, Ivone Jakasa, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMJ Open|July 8, 2022
Opinions on hypertension care and therapy adherence at the healthcare provider and healthcare system level: a qualitative study in the Hague, NetherlandsSaskia E van Grondelle, Sytske van Bruggen, Judith Meijer, et al.
British Journal of Clinical Pharmacology|November 10, 2015
Evaluation of an oral uracil loading test to identify DPD-deficient patients using a limited sampling strategyMaurice C van Staveren, Andre B P van Kuilenburg, Henk-Jan Guchelaar, et al.
Molecular Genetics and Metabolism|October 22, 2017
Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activityYoko Nakajima, Judith Meijer, Doreen Dobritzsch, et al.
Advances in Neurobiology|October 8, 2014
Pregnancy Outcomes After a Maternity Intervention for Stressful Emotions (PROMISES): A Randomised Controlled TrialHuibert Burger, Claudi L H Bockting, Chantal Beijers, et al.
Molecular Genetics and Metabolism|March 27, 2007
Clinical, biochemical and genetic findings in two siblings with a dihydropyrimidinase deficiencyAndré B P van Kuilenburg, Judith Meijer, Doreen Dobritzsch, et al.
International Journal of Cancer|September 21, 2017
Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiencyLinda M Henricks, Ester J M Siemerink, Hilde Rosing, et al.
Human Mutation|April 26, 2018
Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12André B P van Kuilenburg, Maja Tarailo-Graovac, Judith Meijer, et al.
Cancer Chemotherapy and Pharmacology|August 22, 2016
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidinesDidier Meulendijks, Linda M Henricks, André B P van Kuilenburg, et al.
Biochimica Et Biophysica Acta|January 26, 2016
Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase geneAndré B P van Kuilenburg, Judith Meijer, Michael W T Tanck, et al.
The British Journal of Dermatology|January 7, 2022
Children with atopic dermatitis show increased activity of β-glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieuSanja Kezic, Maeve A McAleer, Ivone Jakasa, et al.
Pageof 4